Loading clinical trials...
Loading clinical trials...
A Phase 1, Open-Label, Fixed Sequence Drug-Drug Interaction Study to Evaluate the Effects of Repeat Doses of Ecopipam on the Pharmacokinetics of Multiple Substrates for Drug Metabolism and Transport in Healthy Subjects
Conditions
Interventions
ecopipam HCl ~2mg/kg/day
Cohort 1 Probe Cocktail
+2 more
Locations
1
United States
Syneos Health Clinical Research Services, LLC.
Miami, Florida, United States
Start Date
February 18, 2021
Primary Completion Date
April 2, 2021
Completion Date
May 7, 2021
Last Updated
May 24, 2021
Lead Sponsor
Emalex Biosciences Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions